• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Escitalopram Teva
    / Abic

    Active Ingredient
    Escitalopram 10 mg, 20 mg

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft


    30 X 10 mg

    not in the basket chart 80701 5480


    30 X 20 mg

    not in the basket chart 84783 5496

    Related information


    See prescribing information for full details.


    Treatment of depression. Treatment of panic disorder, generalized anxiety disorder (GAD), social anxiety disorder (SAD) social phobia, obsessive-compulsive disorder (OCD).


    – You are sensitive (allergic) to the active ingredient (escitalopram) or to any of the additional ingredients contained in the medicine.
    – You are taking other medicines from the non-selective, irreversible monoamine oxidase inhibitors (MAOI) group, such as: phenelzine, iproniazid, isocarboxazid, nialamide,  tranylcypromine. Wait 14 days after taking these medicines before beginning to use Escitalopram Teva, or wait 7 days after taking Escitalopram Teva before starting treatment with these medicines. Likewise, do not concomitantly take Escitalopram Teva with MAOAI reversible monoamine oxidase inhibitors (e.g., moclobemide to treat depression) or the nonselective, reversible monoamine oxidase inhibitor (MAOI) linezolid (an antibiotic), or irreversible monoamine oxidase B inhibitors (MAOBI) (e.g., selegiline to treat Parkinson’s). The combination with these medicines increases the risk of serotonin syndrome.
    – You are suffering from heart rhythm disorders (as tested by ECG, a heart function test), or from a congenital defect in the electrical activity of the heart.
    – You are taking medicines to treat heart rhythm disorders or which may have an effect on the heart rhythm.
    – You are taking the medicine pimozide

    Teva Pharmaceutical Industries Ltd, Israel